Navigation Links
drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007
Date:2/6/2008

year-over-year, gross margins up over 300 basis points year-over-year, and core OTC [1] contribution margin dollars up 40% year-over-year. Our core OTC business grew 18% year-over-year, in-line with ecommerce trends, but below our expectations due to increased marketing costs in paid search and portals."

"Throughout 2008, we expect to accelerate our full year top line revenue growth by: increasing sales in each one of our business segments, driving OTC sales by 20% year-over-year and increasing prestige beauty sales more than 40% year-over-year. In the first quarter of 2008, we are making targeted investments in a number of our profitability initiatives including pricing and sourcing to further expand margins. We will start to see the benefits of these investments in the second quarter and we expect to double full year adjusted EBITDA and to exit the year with gross margins above 26% and adjusted EBITDA margins between 5-6%," concluded Ms. Lepore.

GAAP net income for the fourth quarter of 2007 was $156,000, or $0.00 per share, compared to a net loss of $2.9 million, or $0.03 per share, for the fourth quarter of 2006. The fourth quarter in both 2007 and 2006 included $1.7 million in non-cash stock-based compensation expense. GAAP net loss for the fiscal year of 2007 was $9.0 million or $0.09 per share, compared to a net loss of $13.0 million, or $0.14 per share, for the fiscal year of 2006. The fiscal year losses include $8.8 million and $6.7 million, in non-cash stock- based compensation expense for 2007 and 2006, respectively.

Outlook for First Quarter and Fiscal Year 2008

For fiscal year 2008, the company is targeting net sales in the range of $498.0 million to $512.0 million, net income in the range of $(1.0) million to $3.0 million, and adjusted EBITDA in the range of $18.0 million to $22.0 million.

For the first quarter of 2008, the company is targeting net sales in the range of $118.0 million to $122.0 million, net loss in th
'/>"/>

SOURCE drugstore.com, inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007
2. drugstore.com, inc. to Announce Third Quarter 2007 Results During Conference Call on Monday, October 22, 2007 at 5:00 p.m. ET
3. drugstore.com and Revolution Health Group Announce Breakthrough Deal
4. TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
5. Joint Commission International Achieves Accreditation from ISQua
6. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
7. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
8. Pharsight Achieves $7.3 Million in Quarterly Revenue
9. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
10. LMS integrated obstetrics solution achieves general availability
11. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...stress disorder (PTSD) affects as many as one in f...ience like rape, assault, war or terrorism. It has...n up survivors, families. , There is no broadly...eveloping the disorder, but thanks to a Tel Aviv U...g PTSD may be just around the corner. , Prof. Jo...
(Date:12/1/2008)...Newswire/ -- Blue Cross Blue Shield of Michigan,p...and membership information,today to Michigan Atto...rther,information about Michigan,s individual hea...rowth of Michigan,s individual health insurance ma...BCBSM, the state,s last-resort,insurance carrier,...
(Date:12/1/2008).... 1 Seniors who take a close look ...dvantage plans may still realize,savings next yea...ill continue,to offer $0 monthly premiums and $0 ..."gap" or "donut hole" (when beneficiaries pay 100%...-of-pocket costs). HealthMetrix,Research Inc. sc...
(Date:12/1/2008)...RNewswire/ -- Amanzi Tea ( www.amanzitea.com ), a ...in celebration of its first Manhattan location ope...amanzi tea flu shots" made of double strength, fre...13th and 20th from noon until four. This is a hea...with the onset of winter. , , In a recent...
Breaking Medicine News(10 mins):Health News:Easing the stress of trauma 2Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 2Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 3Health News:HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2009 Out-of-Pocket Drug Costs 2Health News:Amanzi Tea offers free, natural 'Flu Shots' to New Yorkers 2
... care to the poor has dropped over the past decade...ca’s quickly growing number of uninsured people. /...r Studying Health System Change, released on Thurs...s provided charity care in the mid-1990s, compared...
... of patients who participated in a UC Davis study ...igh blood pressure. // Conducted by UC Davis card...man clinical trial to assess the effect of grape s...yndrome, a combination of risk factors that increa...
...asaki as a motorcycle rather than a disease. Infac... informed that his 9 year old daughter, Utkarsha w...named so as it is prevalent among Korean and Japan...t I never knew that Kawasaki was a disease,' remar...
...culosis day. It was thought decades ago that the p...y it still remains a major // threat and its toll ...till rising at almost 1% every year despite the ef...culosis has killed about 1.7 million people global...
Other Medicine News:Health News:Fewer Doctors Treating For Free 2Health News:High Blood Pressure Can Be Treated With Grape Seed Extract 2Health News:Low Awareness Of Kawasaki Disease In Capital: Parents Form Support Group 2Health News:Tuberculosis Is Still A Major Health Threat In Africa 2
(Date:12/1/2008)...YMOUTH MEETING, Pa., Dec. 1 /PRNewswire-FirstCall/...nnounced that dosing of subjects has begun in stud...g dose Phase 1b study of trodusquemine (MSI-1436) ... is a novel therapeutic for the treatment of type ...eripherally to regulate insulin and leptin pathway...
(Date:12/1/2008)...LANTA, Dec. 1 GeoVax Lab...sed biotechnology company developing,human vaccin...iency Virus) and,other infectious agents, announc...ccine Trials will take place in twelve sites acros...cted in collaboration with The National Institutes...
(Date:11/30/2008)...ICAGO, Dec. 1 Abnormali...aluated in children with autism spectrum disorder ...o a study presented today at the annual meeting of... , , "Using MEG, we can record the tiny mag...vity," said Timothy Roberts, Ph.D., vice chair of ...
(Date:11/27/2008)...w study finds the majority of acute lymphoblastic ...resent at the time of diagnosis , , MEMPHIS...ists at St. Jude Children,s Research Hospital have...cer cells of children with acute lymphoblastic leu... a pathway to designing treatments for ALL relapse...
Breaking Medicine Technology:Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Cell surface sugar defects may trigger nerve damage in multiple sclerosis patients 1688 1Cell surface sugar defects may trigger nerve damage in multiple sclerosis patients 1688 2UCSD study reveals the regulatory mechanism of key enzyme 1684 1UCSD study reveals the regulatory mechanism of key enzyme 1684 2Controlling for size may also prevent cancer 473 1Controlling for size may also prevent cancer 473 2PSI Brings its Pioneering Efforts to a Close 1677 1PSI Brings its Pioneering Efforts to a Close 1677 2PSI Brings its Pioneering Efforts to a Close 1677 3
...ur breadth of infectious disease ELISA products ma...protocols for faster integration into the busy lab...vide increased reliability and run-to-run consiste...tibody detection assays for a wide range of serolo...
...ur breadth of infectious disease ELISA products ma...protocols for faster integration into the busy lab...vide increased reliability and run-to-run consiste...tibody detection assays for a wide range of serolo...
...ur breadth of infectious disease ELISA products ma...protocols for faster integration into the busy lab...vide increased reliability and run-to-run consiste...tibody detection assays for a wide range of serolo...
...ur breadth of infectious disease ELISA products ma...protocols for faster integration into the busy lab...vide increased reliability and run-to-run consiste...tibody detection assays for a wide range of serolo...
Medicine Products: